Guardant Health Inc. (GH)
BMV
2,784.00
0.00 (0.00%)
Closed
Aug 21, 2026
Day's Range
2,784.002,784.00
52 wk Range
820.002,784.00
Financial Statements - GH - Guardant Health Inc.
Revenue
982.02M▼ 92.3%
Net Income
-416.27M▲ 94.4%Net Margin -42.4%
EBITDA
-373.90M▲ 94.4%
Free Cash Flow
-233.06M▲ 95.1%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 982.02M | 12.68B | 563.94M | 9.17B | 7.62B | 5.85B |
| Cost of Goods | 349M | 4.97B | 227.05M | 3.19B | 2.50B | 1.88B |
| Gross Profit | 633.01M | 7.71B | 336.89M | 5.98B | 5.11B | 3.96B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -437.24M | -7.61B | -564.72M | -11.11B | -8.38B | -5.20B |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -10.49M | -731.48M | 53.17M | -2.29B | 513.96M | 74.32M |
| Pre Tax Income | -417.54M | -7.47B | -478.76M | -13.33B | -7.84B | -5.01B |
| Income Tax | -1.26M | 22.04M | 685K | 23.25M | 6.12M | 7.73M |
| Net Income | -416.27M | -7.49B | -479.44M | -13.36B | -7.85B | -5.02B |
| EPS Basic | -3.32 | -3.56 | -4.28 | -6.41 | -4 | -2.6 |
| EPS Diluted | -3.32 | -3.56 | -4.28 | -6.41 | -4 | -2.6 |
| Basic Shares Outstanding | 125.37M | 2.10B | 5.50M | 102.17M | 101.31M | 97.50M |
| Diluted Shares Outstanding | 125.37M | 2.10B | 5.50M | 102.17M | 101.31M | 97.50M |
| Ebit | -413.64M | -7.42B | -476.18M | -13.28B | -7.79B | -4.92B |
| Ebitda | -373.90M | -6.69B | -433.30M | -12.55B | -7.34B | -4.59B |
| Net Income Continuous Operations | -416.27M | -7.49B | -479.44M | -13.36B | -7.85B | -5.02B |
| Minority Interests | - | - | 0 | 0 | -20.90M | -7.50M |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
